BioCentury | Feb 7, 2018
Distillery Therapeutics

Cancer

...Sylvant siltuximab, a chimeric mAb against IL-6, to treat multicentric Castleman’s disease. XBiotech Inc. and MegaPharm Ltd....
BioCentury | Jul 18, 2016
Company News

Xbiotech, MegaPharm deal

...XBiotech granted MegaPharm rights to commercialize Xilonix in Israel to treat advanced colorectal cancer. XBiotech will...
...payment and is eligible for commercial and regulatory milestones, and XBiotech will provide Xilonix to MegaPharm...
...early as 4Q16. The companies declined to disclose financial terms. XBiotech Inc. (NASDAQ:XBIT), Austin, Texas MegaPharm Ltd....
BioCentury | Jan 27, 2014
Clinical News

Ruconest conestat alfa regulatory update

...Pharming said partner MegaPharm Ltd. (Raanana, Israel) received marketing approval and full reimbursement in Israel for Ruconest...
...for Ruconest conestat alfa to treat acute angioedema attacks in adults with hereditary angioedema (HAE). MegaPharm...
...to launch the recombinant human complement 1 (C1) esterase inhibitor in the country this quarter. MegaPharm...
BioCentury | Oct 28, 2013
Clinical News

Fycompa perampanel regulatory update

...in patients with epilepsy ages >=12 years. Eisai said the drug will be commercialized by MegaPharm Ltd....
BioCentury | Jan 7, 2013
Finance

Buyside View XXI: Sunny side up

Stephen Hansen Senior Writer A strong crop of early PDUFA dates and a sense that FDA is more navigable have given money managers in the U.S. and Europe a positive outlook for 2013, which they...
BioCentury | Aug 13, 2012
Clinical News

Fanapt iloperidone regulatory update

...Israel approved the product as Fanapt to treat schizophrenia. Vanda will supply the product to MegaPharm Ltd....
BioCentury | Jul 2, 2012
Finance

3Q Financial Markets Preview: Miles of milestones

...BLA YE12 Pfizer Inc. (NYSE:PFE) Tofacitinib RA PDUFA date August Pharming Group N.V. (Euronext:PHARM)/Hyupjin Corp. /MegaPharm Ltd./Santarus...
BioCentury | Jun 25, 2012
Company News

EpiCept, Meda sales and marketing update

...retains rights to the histamine receptor agonist in all territories not licensed to Meda or MegaPharm Ltd....
BioCentury | Dec 19, 2011
Company News

MegaPharm, Vanda sales and marketing update

...Vanda granted Megapharm exclusive commercialization rights to schizophrenia drug Fanapt iloperidone in Israel. Vanda said a...
...Israel in May. Vanda will supply the serotonin (5-HT2) receptor and dopamine receptor antagonist to Megapharm...
...option for co-commercialization rights or royalties (see BioCentury, June 14, 2004 & Oct. 19, 2009). Megapharm Ltd....
BioCentury | Jun 13, 2011
Company News

MegaPharm, Pharming sales and marketing update

...Pharming granted MegaPharm Israeli commercialization rights to Ruconest conestat alfa to treat acute attacks of hereditary...
...Israeli commercialization rights to Ruconest conestat alfa to treat acute attacks of hereditary angioedema (HAE). MegaPharm...
...a supply price based on a percentage of net sales. Pharming is eligible for milestones. MegaPharm...
Items per page:
1 - 10 of 15
BioCentury | Feb 7, 2018
Distillery Therapeutics

Cancer

...Sylvant siltuximab, a chimeric mAb against IL-6, to treat multicentric Castleman’s disease. XBiotech Inc. and MegaPharm Ltd....
BioCentury | Jul 18, 2016
Company News

Xbiotech, MegaPharm deal

...XBiotech granted MegaPharm rights to commercialize Xilonix in Israel to treat advanced colorectal cancer. XBiotech will...
...payment and is eligible for commercial and regulatory milestones, and XBiotech will provide Xilonix to MegaPharm...
...early as 4Q16. The companies declined to disclose financial terms. XBiotech Inc. (NASDAQ:XBIT), Austin, Texas MegaPharm Ltd....
BioCentury | Jan 27, 2014
Clinical News

Ruconest conestat alfa regulatory update

...Pharming said partner MegaPharm Ltd. (Raanana, Israel) received marketing approval and full reimbursement in Israel for Ruconest...
...for Ruconest conestat alfa to treat acute angioedema attacks in adults with hereditary angioedema (HAE). MegaPharm...
...to launch the recombinant human complement 1 (C1) esterase inhibitor in the country this quarter. MegaPharm...
BioCentury | Oct 28, 2013
Clinical News

Fycompa perampanel regulatory update

...in patients with epilepsy ages >=12 years. Eisai said the drug will be commercialized by MegaPharm Ltd....
BioCentury | Jan 7, 2013
Finance

Buyside View XXI: Sunny side up

Stephen Hansen Senior Writer A strong crop of early PDUFA dates and a sense that FDA is more navigable have given money managers in the U.S. and Europe a positive outlook for 2013, which they...
BioCentury | Aug 13, 2012
Clinical News

Fanapt iloperidone regulatory update

...Israel approved the product as Fanapt to treat schizophrenia. Vanda will supply the product to MegaPharm Ltd....
BioCentury | Jul 2, 2012
Finance

3Q Financial Markets Preview: Miles of milestones

...BLA YE12 Pfizer Inc. (NYSE:PFE) Tofacitinib RA PDUFA date August Pharming Group N.V. (Euronext:PHARM)/Hyupjin Corp. /MegaPharm Ltd./Santarus...
BioCentury | Jun 25, 2012
Company News

EpiCept, Meda sales and marketing update

...retains rights to the histamine receptor agonist in all territories not licensed to Meda or MegaPharm Ltd....
BioCentury | Dec 19, 2011
Company News

MegaPharm, Vanda sales and marketing update

...Vanda granted Megapharm exclusive commercialization rights to schizophrenia drug Fanapt iloperidone in Israel. Vanda said a...
...Israel in May. Vanda will supply the serotonin (5-HT2) receptor and dopamine receptor antagonist to Megapharm...
...option for co-commercialization rights or royalties (see BioCentury, June 14, 2004 & Oct. 19, 2009). Megapharm Ltd....
BioCentury | Jun 13, 2011
Company News

MegaPharm, Pharming sales and marketing update

...Pharming granted MegaPharm Israeli commercialization rights to Ruconest conestat alfa to treat acute attacks of hereditary...
...Israeli commercialization rights to Ruconest conestat alfa to treat acute attacks of hereditary angioedema (HAE). MegaPharm...
...a supply price based on a percentage of net sales. Pharming is eligible for milestones. MegaPharm...
Items per page:
1 - 10 of 15